We have cloned two novel, alternatively spliced messages of human cyclin D-binding myb-like protein (hDMP1). The known, full-length protein has been named hDMP1a and the new isoforms hDMP1b and hDMP1g. The hDMP1a, b, and g splice variants have unique expression patterns in normal hematopoietic cells; hDMP1b mRNA transcripts are strongly expressed in quiescent CD34
INTRODUCTION
The 761-amino-acid mouse cyclin D-binding myb-like protein (mDmp1) transcription factor was first identified using cyclin D2 as bait in a yeast two-hybrid screen and human DMP1 was cloned shortly thereafter (1, 2) . Both mouse and human DMP1 are composed of a central domain containing three myb-like repeats flanked by an acidic transactivation and a cyclin binding domain on the N terminus and an acidic transactivation domain at the C terminus (3) . In humans, hDMP1 mRNA is ubiquitously expressed at low levels in normal human tissues, with highest expression levels in testis, spleen, thymus and peripheral blood leukocytes (2) .
Interestingly the hDMP1 locus is localized on chromosome 7q21, a region frequently deleted as part of the 7q-minus and monosomy 7 abnormalities of acute myeloid leukemia and myelodysplastic syndrome. DMP1 binds to nonameric Ets consensus DNA sequences containing G-G/T-A cores, competes with Ets-family proteins, and has been shown to be a transcriptional activator (1) . DMP1 binding sites are found in the promoters of two well-known genes, CD13/aminopeptidase N (APN) and the mouse tumor suppressor p19 ARF (also referred to as ARF or p14 ARF in humans) which is encoded from the Ink4a-Arf locus (4).
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hematopoietic and endothelial cells reviewed in Riemann et al. (10) . A direct role for CD13/APN has been proposed for human dendritic cell development in culture (13) . In myeloid cells it has been shown that c-Myb, Ets family members and mDmp1 regulate CD13/APN transcription (6) .
Activation of CD13/APN gene expression is enhanced by a cooperative interaction between cMyb bound to its cognate site and mDmp1 bound to one of the three downstream GGA core sites (6) . Thus, CD13/APN promoter activity requires the intact DNA binding and transactivation domains of mDmp1, since mutants disrupted in either domain are biologically inert. Intriguingly, that c-Myb and mDmp1 show synergistic effects in activating the CD13/APN promoter implies that two different Myb family proteins collaborate in regulating CD13/APN gene expression and points to an important role for DMP1 in normal myeloid cell development (6) .
Herein, we describe two new splice variants of human DMP1 message generated by alternative splicing through the use of two different splice acceptor sites. We propose that the previously cloned hDMP1 message (2) be termed hDMP1a and the new splice variants hDMP1b
and g. Distinct patterns of hDMP1a, b, and g-mRNA transcript expression in primary myeloid and lymphoid cells during in vitro development led us to consider the possibility that alternative hDMP1b and g isoforms might have distinct cellular functions as compared to hDMP1a. We confirm a role for the original DMP1 isoform, hDMP1a, in activation of CD13/APN gene expression (6) and document antagonistic functional properties for the hDMP1b isoform in 6
Cell culture -Cord blood CD34 + cells were differentiated in culture to either neutrophils or monocytes during a 15-day period with combinations of human recombinant cytokines. Initially, CD34 + cells were cultured in 10% BIT 9500 (StemCell Technology, Vancouver, Canada)
supplemented serum-free IMDM medium containing hrSCF (300 ng/ml), hrG-CSF (10 ng/ml), hrIL-6 (10 U/ml), hrGM-CSF (50 ng/ml) and hrFL (300 ng/ml) to expand primitive progenitors.
Growth factors were purchased from PeproTech (Rocky Hill, NJ USA). All cultures were maintained in a 37°C humidified incubator, containing 5% CO 2 . After four days of culture the cells were removed, washed, and the medium was changed to Myelocult™ H5100 (StemCell Technology, Vancouver, Canada) containing hrSCF (300 ng/ml), hrGM-CSF (10 ng/ml), hrIL-6
(10 U/ml) and hrIL-3 (10 ng/ml) to promote expansion of primitive myeloid progenitors. On day 10 of the cultures cells were removed, washed, and resuspended in either Myelocult™ hrG-CSF (10 ng/ml) for neutrophil development or Myelocult and hrM-CSF (5000 U/ml) for monocyte/macrophage development. Stage of development was assessed on cellular morphology and stage-specific cell surface markers using flow cytometry and appropriate antibody reagents (14, 17, 18) . To obtain peripheral blood derived macrophages 2x10 6 PBMNCs in 1 ml of RPMI containing 10% fetal bovine serum (FBS) (Hyclone, Ogden, UT), 2mM L-glutamine, and 7 Louis, MO). Briefly, PMA first was dissolved in DMSO at a concentration of 1.0 x 10 -4 M. For macrophage differentiation, PMA was diluted to concentrations as indicated in C-DMEM and cells were cultured at a density of 0.3x10 6 cells per ml for 1-4 days. All cultures were maintained in a 37˚C humidified incubator containing 10% CO 2 .
Non-adherent PBMNC were cultured in C-RPMI on 12-well plates pre-coated with anti-CD3 (1 µg/ml; Becton-Dickinson, BD Biosciences, San Jose, CA) and anti-CD28 (1 µg/ml; Becton-Dickinson) antibody for T-cell activation. Activation of T-cells was measured by FACS analysis of the CD69 surface marker (PerCP-conjugated CD69 antibody, Becton-Dickinson)
after six days of incubation in a 37˚C humidified incubator containing 5% CO 2 . In vitro transciption and translation of hDMP1 isoforms-Cell-free transcription and translation of hDMP1a, b, and g plasmid DNA was performed using the TnT T7-coupled reticulocyte lysate system (TnT® system) and the Transcend™ non-radioactive translation detection system according to the manufacturer's instructions (Promega Morphological Evaluation -Morphological features of differentiated U937 VIPER and VIPERb cell were reviewed on cytospin slide preparations stained with May-Gruenwald-Giemsa stain.
Expression plasmid and HIV vector construction and preparation of vector stocks-hDMP1a
Classically defined morphological features were used as indicators of macrophage differentiation including cell shape, adherence, ratio of cytoplasmic region to nuclei and cytoplasmic granulation. respectively, at nt 985 (accession no. AF084530). These sequences are identical to the genomic sequence of intron 9 and were generated by alternative splicing using two putative splicing acceptor sites as seen in Table 1 . Based on our findings we now propose to refer to hDMP1 as hDMP1a and the new splice variants as hDMP1b and g, respectively (accession no. AF202144
RESULTS

Genomic organization and translation of the human DMP1 gene and its splice variants-
and AF202145). The open reading frames of hDMP1b and g encode identical initial amino acid (aa) sequences to hDMP1a up to the splice site at aa 237. However, after aa 237 hDMP1b and g show novel stretches of 35 and 48 aa, respectively, followed by a premature TAA stop signal occurring in the alternatively spliced intronic sequence (Fig. 1B) . The newly defined hDMP1 confirmed by phenotypic and morphologic criteria. After one day of differentiation a marked down-regulation of hDMP1b was observed (Fig. 2C ). During the entire differentiation period relative levels of hDMP1b stayed low whereas hDMP1a was the predominant splice variant identified. There were no substantial changes in hDMP1g transcript expression. In contrast, terminally differentiated neutrophils expressed relatively lower amounts of all hDMP1 splice variants, but increased amounts of hDMP1a vs. hDMP1b, whereas monocytes expressed, relatively, higher amounts of hDMP1a transcripts. Assessment of hDMP1 transcripts from freshly isolated neutrophils obtained from blood confirmed (data not shown) what was seen in culture-derived neutrophils, the predominance of hDMP1a as compared to hDMP1b and lower amounts of total transcripts.
In summary, hDMP1 splice variants were expressed in all hematopoietic lineages evaluated. However, distinct patterns of hDMP1a and hDMP1b RNA transcript expression were found in freshly isolated CD34 + cord blood progenitor cells and PBMNCs when compared to differentiating myeloid cells. Moreover, monocytes, macrophages and neutrophils expressed increased relative hDMP1a RNA transcripts levels. In all cell lineages assessed hDMP1g transcripts were less abundant compared to the other splice variants and transcript levels did not appreciably change during myeloid differentiation. Recently it has been reported that mDmp1 is increased in cells that are not actively cycling (1, 3) . Interestingly, it was found that freshly isolated CD34 + cells, a cell population reported to be not actively cycling, have increased relative levels of hDMP1b as compared to hDMP1a, whereas CD34 + cells undergoing myeloid differentiation and terminally differentiated, non-cycling macrophages and neutrophils demonstrated increased relative hDMP1a transcripts levels as compared to hDMP1b.
Expression patterns of hDMP1 mRNA splice variants in T cells obtained from peripheral blood-
It has been reported that mDmp1 was strongly expressed in the mouse thymus, which is primarily comprised of activated, cycling and differentiating T cells (25) . In contrast, T cells isolated from the peripheral blood are not highly activated or cycling and differing patterns of hDMP1 splice variants might be associated with non-activated vs. activated T cells and may provide additional information on correlative roles of hDMP1 splice variants. Interestingly, it has been shown that T-cell activation leads to CD13/APN cell surface expression (26,27) and CD13 activation has been reported, in part, to be possibly regulated by mDmp1 (6) . To determine whether hDMP1 splice variant patterns and CD13/APN cell surface expression was associated with hDMP1a and hDMP1b transcript changes in T cells, we compared relative hDMP1 transcript levels in activated versus non-activated T-cells. Flow cytometry analysis was used to evaluate increases in CD69 expression, a positive control for T-cell activation, on freshly isolated PBMNC and after 6 days of CD3/CD28 antibody activation. It has been shown previously that CD13/APN expression is increased after T-cell receptor mediated activation (26).
As can be seen in Fig. 3 this increased CD13/APN surface expression is paralleled by a significant decrease in relative amounts of hDMP1b transcripts, as compared to a, resulting in an increase in the hDMP1a/b ratio (Mann-Whitney U, P=0.0172). These data support an association between the appearance of CD13/APN cell surface expression and an increase in the hDMP1a/b ratio after T cell activation. containing plasmids in 293T significantly increased luciferase activity at levels 20-fold above that seen with the empty control plasmid (Fig. 4A ). This is within the range of activation reported with mouse Dmp1 (1). In contrast, hDMP1b and g containing plasmids when cotransfected with pGL2-BS2 did not activate gene expression and interestingly hDMP1b decreased basal luciferase activity as compared to the control, non-hDMP1 containing plasmid (Fig. 4A ). These findings suggest that unlike the hDMP1a isoform, both the hDMP1b and g isoforms may not function as transcriptional activators.
Transactivation by hDMP1a is repressed by hDMP1b and to a lesser degree by hDMP1g-
Given that hDMP1b and g isoforms did not function as transcriptional activators, we next investigated whether their effect was transcriptionally neutral or repressive in the presence of the hDMP1a isoform. This was assessed by co-transfection of constant amounts of the hDMP1a plasmid with increasing amounts of either hDMP1b or hDMP1g containing plasmids. As can be seen in Fig. 4B upper panel, co-transfection of hDMP1b plasmid resulted in a dose-dependent inhibition of hDMP1a-induced transactivation. Interestingly, this effect was not seen when hDMP1g plasmid was co-transfected with hDMP1a ( Fig. 4B , lower panel) Thus, hDMP1b but not hDMP1g, has a dominant-negative effect on the transactivation potential of hDMP1a.
The myeloid and T cell CD13/APN promoter, pMyo, was evaluated (28) to further investigate the function of hDMP1b and g as repressors of hDMP1a-mediated activation. It has been reported that mDmp1 and c-Myb synergize to transactivate CD13/APN gene expression (6) . The CD13/APN promoter reporter may provide a more physiological situation than the minimal DMP1 consensus binding site reporter by allowing interaction of additional transcription factors, such as Ets-1 and Ets-2 to regulate CD13/APN gene expression (6) . As shown in Fig. 4C the strong dominant-negative effect of hDMP1b on the transactivation activity of hDMP1a was evident. In contrast to the DMP1 consensus site reporter, modest inhibition by hDMP1g was found. However, hDMP1g repression of hDMP1a activity was less pronounced than that of hDMP1b and was not dose-dependent. These results show using both an artificial, DMP1 consensus binding site and the myeloid/T cell CD13/APN promoter that both novel isoforms do not transactivate and that hDMP1b significantly inhibits the transactivation activity of hDMP1a. (Fig. 2C) , we have seen a significant decrease in relative amounts of hDMP1b transcripts upon PMA-induced differentiation of U937 cells to macrophages (Fig. 6A) . In contrast, the hDMP1g transcript levels did not change. These findings suggested that a decrease in hDMP1b expression is associated with cytokine activation and differentiation.
Stable U937cell line transfectants of hDMP1b and hDMP1g show reduced CD13/APN levels-
To determine whether changes in the hDMP1a:hDMP1b RNA transcript ratio in favor of hDMP1b, i.e. increasing the cellular levels of the hDMP1b isoform, alter myeloid differentiation, U937 cells stably expressing hDMP1b (VIPERb) or only the control tNGFR reporter (VIPER) were differentiated to macrophages. Alterations in CD11c expression, cell morphology, and proliferation were quantified to evaluate the effects of hDMP1b on cellular function during differentiation. Differentiation of U937 cells to macrophages using PMA, is characterized by monocyte/macrophage specific gene expression (e.g. CD11c, CD11b) and (Fig 6B) . Additionally, there were minor morphological alterations in nuclear to cytoplasmic ratio in PMA-induced U937 VIPERb cells as compared to VIPER control cells cultured under identical conditions. Only 88% of the U937 VIPERb cells showed a nuclear to cytoplasmic ratio ranging from 1:2 to 1:4 as compared to 99% of the U937 VIPER cells. Overall, these findings suggest that ectopic expression of hDMP1b altered some phenotypic and morphological markers associated with macrophage differentiation although adherent macrophages were nonetheless generated.
Continued proliferation of U937 VIPERb cells during PMA-induced macrophage differentiation-
Loss of cell proliferation is associated with terminal differentiation of U937 cells to macrophages. We observed that the pattern of cell proliferation during terminal differentiation to macrophages was altered in VIPERb cells, as compared to VIPER control cells (Fig. 7) . U937
VIPERb, in contrast to VIPER cells, maintained significantly higher proliferation when treated with 1, 3, or 10 nM PMA, a concentration range sufficient to induce macrophage differentiation in VIPER control cells. In summary, U937 VIPER cells treated with increasing PMA concentration showed a proliferation reduction of 9-72% on day one and of 44-88% on day two compared to VIPERb cells. On day two at the highest concentration of PMA used at least 95% of the U937 VIPER and VIPERb cells were macrophages as judged by morphology. At day four, the two cell lines did not show significant differences in development (not shown).
DISCUSSION
The analysis of two unique hDMP1 message sequences isolated from myeloid cells revealed sequence identity corresponding to the use of intron 9 and further analysis indicate the presence of novel splice-acceptor sites in intron 9. These intronic insertions led to a frameshift and premature termination signals resulting in the truncation of full-length hDMP1 protein. The truncated hDMP1b and g isoforms contain only a small segment of the myb-like homology domain and none of the C-terminal transactivation domain (Fig. 1B) . Proteins corresponding to the correct size for the hDMP1b or g open reading frame were identified by cell-free translation.
Studies in mice have reported a single mouse Dmp1 message and differing molecular weights of mDmp1 proteins in the 125 kDa range which have been attributed to phosphorylation differences but 78 and 58 kDa protein species were also found. These shorter variants were only precipitated with antiserum against the N-terminus and may represent C-terminal truncated mDmp1 proteins In conclusion, we report herein the cloning of human hDMP1b and g and document unique hDMP1b and g expression patterns associated with activation and differentiation.
HDMP1b, and to some degree hDMP1g, represses hDMP1a activity and ectopic expression of hDMP1b reduces cell surface expression of CD13/APN. Regulation of hDMP1a function may represent an additional cellular mechanism by which hDMP1a activated genes, e.g. CD13/APN, an important player in myeloid differentiation and lymphocyte activation, are controlled. Ectopic expression of hDMP1b leads to maintenance of proliferation in myeloid cells undergoing terminal maturation. These findings suggest that the ratio of hDMP1a:hDMP1b maybe critical for regulating proliferation at various stages of hematopoietic development. Additional studies are now needed to fully address the physiological significance of hDMP1 isoforms in p14 ARF and non-ARF regulated cell cycle pathways during hematopoietic development.
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We gratefully acknowledge Dr. Peggy Just for her careful reading of the manuscript and helpful suggestions. This is publication 15453-MEM from The Scripps Research Institute. hDMP1 and GAPDH PCR products were run on 2.5 and 1.5% agarose gels, respectively. C, Cord blood derived CD34 + cells were in vitro expanded and differentiated to neutrophils using hrG-CSF and to monocytes using hrM-CSF as described in Experimental Procedures. Cells were harvested at the days indicated and total RNA was extracted. RT-PCR analysis of hDMP1 splice variants was performed as described. Densities of the RT-PCR bands were measured using EagleEye software and a:b and a:g ratios were calculated. a:b ratios are displayed below the respective PCR bands, a:g ratios did not change. Representatives are shown from at least twice repeated experiments. GAPDH message expression levels served as controls for total mRNA integrity and to determine whether equal amounts of RNA were amplified. and densitometric analysis was performed as described in Figure 2C . GAPDH transcript levels served as total mRNA controls. Table 1 Exon-intron boundaries of hDMP1a. The positions of the exons are given according to the numbering of the hDMP1 cDNAsequence (GenBank accession no. AF084530). The splice acceptor and donor sites are shown in bold, the alternative 3' splice acceptor sites producing exon 10b and g are boxed. 
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